[HTML][HTML] Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - EBioMedicine, 2021 - thelancet.com
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
[HTML][HTML] Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - EBioMedicine, 2021 - ncbi.nlm.nih.gov
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - EBioMedicine, 2021 - pubmed.ncbi.nlm.nih.gov
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers.
G Cui, Q Fan, Z Li, R Goll, J Florholmen - Ebiomedicine, 2021 - europepmc.org
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
[PDF][PDF] Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - 2021 - nordopen.nord.no
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
[HTML][HTML] Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - eBioMedicine, 2021 - Elsevier
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
[PDF][PDF] Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
G Cui, Q Fan, Z Li, R Goll, J Florholmen - 2021 - core.ac.uk
Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal …